The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
69645128 6964512 8 F 20090331 20121219 20090409 20121231 EXP JP-BRISTOL-MYERS SQUIBB COMPANY-14575484 BRISTOL MYERS SQUIBB 54.00 YR M Y 0.00000 20121231 CN JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
69645128 6964512 1 PS SPRYCEL 1 ORAL D 21986 70 MG BID
69645128 6964512 2 SS AMBISOME 1 INTRAVENOUS INITIATED ON 30MAR09 INJ D 0 150 MG
69645128 6964512 3 C VINDESINE SULFATE 1 INTRAVENOUS FORM:INJ 23JAN-11FEB09,1MG:18MAR-18MAR09. D 0 1 MG
69645128 6964512 4 C PREDNISOLONE 1 ORAL TABS:29MAR09-01APR09 INV:02APR09-03APR09 D 0 40 MG
69645128 6964512 5 C OMEPRAZOLE 1 INTRAVENOUS INJ D 0 40 MG
69645128 6964512 6 C IMATINIB MESILATE 1 ORAL 400 - 800 MG D 0 1 DF
69645128 6964512 7 C VINCRISTINE SULFATE 1 INTRAVENOUS D 0 2 MG
69645128 6964512 8 C ITRACONAZOLE 1 ORAL FORM:TABS D 0 20 ML
69645128 6964512 9 C DINOPROST 1 INTRAVENOUS INJ D 0 1 MG
69645128 6964512 10 C MICAFUNGIN SODIUM 1 INTRAVENOUS INJ D 0 150 MG
69645128 6964512 11 C DOBUTAMINE HCL 2 INTRAVENOUS 1 DOSAGE FORM = 10 GAMMA INJ D 0 1 DF
69645128 6964512 12 C TRANEXAMIC ACID 1 INTRAVENOUS INJ D 0 1 G
69645128 6964512 13 C ZOPICLONE 1 INTRAVENOUS 1 DOSAGE FORM = 10 GAMMA INJ D 0 1 DF
69645128 6964512 14 C MAXIPIME FOR INJ 2 INTRAVENOUS D 0 3 G Injection

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
69645128 6964512 1 Chronic myeloid leukaemia
69645128 6964512 3 Chronic myeloid leukaemia
69645128 6964512 6 Chronic myeloid leukaemia
69645128 6964512 7 Chronic myeloid leukaemia

Outcome of event

Event ID CASEID OUTC COD
69645128 6964512 LT
69645128 6964512 OT
69645128 6964512 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
69645128 6964512 Acute pulmonary oedema
69645128 6964512 Blood creatine phosphokinase increased
69645128 6964512 Gastrointestinal haemorrhage
69645128 6964512 Generalised oedema
69645128 6964512 Multi-organ failure
69645128 6964512 Muscular weakness
69645128 6964512 Renal failure
69645128 6964512 Shock haemorrhagic

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
69645128 6964512 1 20090330 20090401 0
69645128 6964512 2 20090330 20090401 0
69645128 6964512 3 20090318 20090318 0
69645128 6964512 4 20090329 20090403 0
69645128 6964512 5 20080331 20090405 0
69645128 6964512 6 20080514 20090329 0
69645128 6964512 7 20090123 20090211 0
69645128 6964512 8 20090218 20090405 0
69645128 6964512 9 20090301 20090405 0
69645128 6964512 10 20090331 20090404 0
69645128 6964512 11 20090402 20090404 0
69645128 6964512 12 20090401 20090401 0
69645128 6964512 13 20090402 20090404 0
69645128 6964512 14 20090331 20090403 0